Workflow
中国贵妇又捧出一个IPO
投中网·2025-06-15 06:47

Core Viewpoint - The article highlights the remarkable growth and transformation of Lin Qingxuan, a Chinese skincare brand, under the leadership of its founder Sun Laichun, emphasizing its journey from near bankruptcy to becoming a leading player in the high-end skincare market with a focus on camellia oil products [4][5][10]. Group 1: Company Overview - Lin Qingxuan was founded by Sun Laichun, who registered the brand name 20 years ago, and has since become a benchmark in the anti-wrinkle skincare sector in China [5][6]. - The brand has achieved significant sales milestones, with a cumulative sales volume of 30 million bottles of its star product, the camellia oil, and has maintained the top position in facial oil sales in China for 11 consecutive years [8][10]. Group 2: Financial Performance - Lin Qingxuan's revenue is projected to grow from 6.91 billion yuan in 2022 to 12.10 billion yuan in 2024, marking a 75% increase [10]. - The net profit has reversed from a loss of 5.93 million yuan to a profit of 1.87 billion yuan during the same period [10]. - The camellia oil product line has seen revenue growth from 2.18 billion yuan to 4.48 billion yuan, increasing its share of total revenue from 31.5% to 37% [11]. Group 3: Market Position and Strategy - Lin Qingxuan has positioned itself as a high-end domestic skincare brand, ranking first in retail sales among Chinese high-end skincare brands and being the only domestic brand in the top 15 of high-end skincare brands in China [11]. - The company has successfully transitioned to online sales, with online revenue reaching 7.14 billion yuan in 2024, accounting for 59.1% of total revenue [12]. Group 4: Future Plans and Market Trends - Lin Qingxuan plans to use IPO funds to enhance its high-end domestic brand image, expand into Southeast Asia, and develop new anti-wrinkle technologies [15]. - The high-end anti-wrinkle skincare market in China is expected to grow at a compound annual growth rate of 21.2%, from 59.4 billion yuan in 2024 to 155.5 billion yuan by 2029 [15].